FilingSEC EDGAR6-K
Eupraxia Pharmaceuticals to Participate in Investor Conferences and Host Virtual Analyst Day
· SEC accepted
StageClinical-stage
Filing content
Eupraxia Pharmaceuticals announced its participation in upcoming investor conferences and will host a virtual Analyst Day on November 13 to discuss its EP-104GI program for eosinophilic esophagitis.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…